Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Ueda

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.
Journal of Surgical Case Reports|January 8, 2026
Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancerHideya Onishi, Atsushi Higa, Mayu Tasaki, et al.
International Journal of Surgery Case Reports|July 24, 2020
A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node MetastasesMasanori Tsujie, Soichi Fumita, Tomoko Wakasa, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trialKohei Shitara, Atsuo Takashima, Kazumasa Fujitani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trialShuichi Hironaka, Shinya Ueda, Hirofumi Yasui, et al.
International Journal of Clinical Oncology|January 19, 2011
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatinYasuhiro Kidera, Taroh Satoh, Shinya Ueda, et al.
The Oncologist|November 15, 2018
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal CancerYoshihiko Fujita, Masataka Taguri, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2018
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched studyAkitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumorsTaroh Satoh, Isamu Okamoto, Masaki Miyazaki, et al.
Journal of Surgical Case Reports|January 8, 2026
Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancerHideya Onishi, Atsushi Higa, Mayu Tasaki, et al.
International Journal of Surgery Case Reports|July 24, 2020
A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node MetastasesMasanori Tsujie, Soichi Fumita, Tomoko Wakasa, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trialKohei Shitara, Atsuo Takashima, Kazumasa Fujitani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: WJOG 4007 trialShuichi Hironaka, Shinya Ueda, Hirofumi Yasui, et al.
International Journal of Clinical Oncology|January 19, 2011
High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatinYasuhiro Kidera, Taroh Satoh, Shinya Ueda, et al.
The Oncologist|November 15, 2018
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal CancerYoshihiko Fujita, Masataka Taguri, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 22, 2018
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched studyAkitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, et al.
Pageof 6